Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Molecular Biology Reports|November 29, 2024
RNA methylation and breast cancer: insights into m6A, m7G and m5CYuhan Dai, Shuhan Zhao, Huilin Chen, et al.Regenerative Therapy|November 18, 2024
Autologous fat grafting for postoperative breast reconstruction: A systemic reviewWenxin Yu, Zhenghui Wang, Yuhan Dai, et al.Fish & Shellfish Immunology|June 20, 2021
RIPK3 collaborates with RIPK1 to inhibit MAVS-mediated signaling during black carp antiviral innate immunityYuhan Dai, Yingyi Cao, Zhaoyuan Chen, et al.Journal of Cellular and Molecular Medicine|August 22, 2025
N7-Methylguanine-Related Gene Signature Highlights EIF4E as a Novel Therapeutic Target in HER2-Negative Breast CancerYangyang Cui, Yuhan Dai, Yiqin Xia, et al.Fish & Shellfish Immunology|April 26, 2020
Black carp TRAFD1 restrains MAVS-mediated antiviral signaling during the innate immune activationJun Yan, Yinyin Zhang, Yaqi Tan, et al.Water Environment Research : a Research Publication of the Water Environment Federation|September 20, 2024
Dynamic analysis of groundwater chemistry from 1997 to 2018 in the eastern part of Yongning County, Ningxia Hui Autonomous Region of northwestern China: Integration of Bayesian water quality assessment and health risk assessmentYahong Zhou, Yingqiu Xia, Jingkai Zhou, et al.Iscience|February 23, 2024
Acute kidney injury prediction model utility in premature myocardial infarctionFang Tao, Hongmei Yang, Wenguang Wang, et al.Fish & Shellfish Immunology|January 29, 2021
Black carp TRADD suppresses MAVS/IFN signaling during the innate immune activationWanzhen Li, Yingyi Cao, Zhaoyuan Chen, et al.Developmental and Comparative Immunology|May 8, 2020
Black carp RIPK1 negatively regulates MAVS-mediated antiviral signaling during the innate immune activationXinchi Xie, Yingyi Cao, Yuhan Dai, et al.Translational Oncology|February 22, 2025
Mitochondrial metabolism-related features guiding precision subtyping and prognosis in breast cancer, revealing FADS2 as a novel therapeutic targetYakun Kang, You Meng, Jiangdong Jin, et al.Pageof 4